Kane Biotech Inc. (KNBIF)
OTCMKTS · Delayed Price · Currency is USD
0.0300
+0.0063 (26.48%)
Aug 7, 2025, 11:17 AM EDT
The Aaron's Company Market Cap
Kane Biotech has a market cap or net worth of $4.83 million as of August 8, 2025. Its market cap has decreased by -63.07% in one year.
Market Cap
4.83M
Enterprise Value
5.97M
Revenue
1.70M
Ranking
n/a
PE Ratio
1.11
Stock Price
$0.03
Market Cap Chart
Since May 20, 2003, Kane Biotech's market cap has increased from 764.76K to 4.83M, an increase of 531.04%. That is a compound annual growth rate of 8.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 4.83M | -54.09% |
| Dec 31, 2024 | 10.51M | 31.63% |
| Dec 29, 2023 | 7.99M | -3.79% |
| Dec 30, 2022 | 8.30M | -40.97% |
| Dec 31, 2021 | 14.06M | 17.84% |
| Dec 31, 2020 | 11.93M | 8.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 604.98M |
| Glass House Brands | 474.59M |
| Northwest Biotherapeutics | 365.69M |
| American Oncology Network | 330.70M |
| CytoDyn | 328.51M |